Bone loss and the evolving role of bisphosphonate therapy in prostate cancer
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 21 (5) , 392-398
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Medicare Spending For Injured Elders: Are There Opportunities For Savings?Health Affairs, 2002
- The Incidence of Vertebral Fractures in Men and Women: The Rotterdam StudyJournal of Bone and Mineral Research, 2002
- Studies on prostatic cancerJournal of Urology, 2002
- Mortality and Institutionalization Following Hip FractureJournal of the American Geriatrics Society, 2000
- Potential side-effects of endocrine treatment of long duration in prostate cancerThe Prostate, 2000
- A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging MenJournal of Bone and Mineral Research, 1998
- Osteoporosis in MenDrugs & Aging, 1998
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis studyJournal of Bone and Mineral Research, 1996
- Age-related hip fractures in men: Clinical spectrum and short-term outcomesOsteoporosis International, 1995